Arvinas (ARVN) Return on Capital Employed (2018 - 2026)

Arvinas (ARVN) recorded quarterly Return on Capital Employed of 44.76% in Q1 2026, down 141.21% quarter-over-quarter from 18.56% in Q4 2025, and down 3327.0% on a YoY basis from 1.39% in Q1 2025.

Arvinas (ARVN) Return on Capital Employed (2018 - 2026) Analysis & Trends

Arvinas' Return on Capital Employed history runs 9 years deep, the most recent figure standing at 44.76% for Q1 2026.

  • In Q1 2026, Return on Capital Employed fell 3327.0% year-over-year to 44.76%; the TTM figure through Mar 2026 stood at 44.76% (down 3327.0% YoY), while the FY2025 annual figure was 15.55%, up 1029.0% from the prior year.
  • Return on Capital Employed was 44.76% for Q1 2026 at Arvinas, down from 18.56% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 11.49% in Q1 2025 to a low of 44.76% in Q1 2026.
  • Historically, Return on Capital Employed has averaged 28.42% across 5 years, with a median of 27.83% in 2024.
  • The sharpest annual moves came in 2025 and 2026: Return on Capital Employed jumped 2753 bps in 2025, then slumped 3327 bps in 2026.
  • A 5-year view of Return on Capital Employed shows it stood at 26.16% in 2022, then sank by 66 bps to 43.44% in 2023, then soared by 36 bps to 27.83% in 2024, then soared by 33 bps to 18.56% in 2025, then slumped by 141 bps to 44.76% in 2026.
  • The last three Return on Capital Employed figures came in at 44.76% (Q1 2026), 18.56% (Q4 2025), and 13.95% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Arvinas 492.16 Mn -122.74 Mn - -44.76%

Historic Data

Download Data
DateValue
Mar 31, 2026 -44.76%
Dec 31, 2025 -18.56%
Sep 30, 2025 -13.95%
Jun 30, 2025 -14.87%
Mar 31, 2025 -11.49%
Dec 31, 2024 -27.83%
Sep 30, 2024 -37.72%
Jun 30, 2024 -41.27%
Mar 31, 2024 -39.02%
Dec 31, 2023 -43.44%
Sep 30, 2023 -41.37%
Jun 30, 2023 -36.73%
Mar 31, 2023 -31.23%
Dec 31, 2022 -26.16%
Sep 30, 2022 -20.89%
Jun 30, 2022 -18.05%
Mar 31, 2022 -15.76%
Dec 31, 2021 -14.15%
Sep 30, 2021 -19.12%
Jun 30, 2021 -26.49%